.png)
What We Do
D4 Bioventures is a venture studio and boutique corporate advisory firm dedicated to transforming life science and healthcare innovations into well-funded, market-ready enterprises. We specialise in venture building for universities and medical research institutes, and in capital raising and corporate structuring for life science and health sector companies. Whether you are looking to take an early-stage technology from research to funded spin-out, or are an established Biotech, Medtech or Healthtech seeking to raise capital, we are here to guide you every step of the way.
Focus Areas
D4 Bioventures is dedicated to driving innovations in biomedical and life science-focused technologies across multiple domains, including Drugs, Devices, Diagnostics, and Digital Health. These areas present vast opportunities, from ground-breaking therapeutic treatments and advanced medical devices to transformative digital health solutions and precise diagnostic tools. Through targeted incubation and strategic advisory, D4 Bioventures aims to harness these opportunities, fostering enterprises set to reshape global healthcare's future.
Expert Team
Andrew Silberberg, Jeremy Waine, David Barda, and Steven Suchting bring a wealth of expertise to D4 Bioventures. Their diverse backgrounds in corporate law, investment banking, venture capital and life science technology commercialisation provide clients with unmatched insights, leadership, and industry connections. With decades of collective experience, our team is equipped to guide you through every stage of your journey.